Brainomix
Brainomix is an artificial intelligence company in Oxford, United Kingdom, founded in 2010. It has raised $24.5M across 2 rounds, most recently a $6.5M Extension Round in February 2026.
AI-powered imaging biomarkers for better life-saving decisions
- Headquarters
- Oxford
- Employees
- 51–200
- Founded
- 2010
- Business Model
- B2B
- Website
- brainomix.com
- Total Funding
- $24.5M
- Last Round
- $6.5M Extension RoundFeb 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.
About
Brainomix is a University of Oxford spin-out specializing in the creation of AI-powered imaging biomarkers and software solutions that enable precision medicine and better clinical treatment decisions. Founded in 2010 by Michalis Papadakis and Andrew Charles Barker, the company's flagship product—Brainomix 360—is a comprehensive stroke AI imaging platform that provides real-time analysis tools including e-ASPECTS, e-CTA, e-CTP, and e-MRI to support neurologists, interventionalists, and radiologists. The platform is used in over 30 countries, processes a patient scan every 3 minutes, and is backed by 56+ clinical publications. Brainomix also has an e-Lung product for automated AI-powered solid tumor assessment. The company is backed by Boehringer Ingelheim Venture Fund, Parkwalk, and IP Group Hostplus Innovation Fund, and has received FDA clearance for its stroke AI imaging software.
Summary
It lists 51–200 employees. It has raised $24.5M in total across 2 rounds, most recently a $6.5M Extension Round in Feb 2026. Investors include Hostplus, Parkwalk Advisors and Boehringer Ingelheim Venture Fund.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2026
Sign up to see all 2 events
Funding: Series C through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/brainomix"><img src="https://indexed.vc/api/badge/company/brainomix" alt="Brainomix on Indexed.vc" width="260" height="76" /></a>